LEADER 00917nam0-22003011i-450-
001 990000101450403321
035   $a000010145
035   $aFED01000010145
035   $a(Aleph)000010145FED01
035   $a000010145
100   $a20011111d--------km-y0itay50------ba
101 0 $aita
105   $ay-------001yy
200 1 $aHorizontal wells$ea new application of geological principles to effects the solution of the problem of supplyng Londonwith pure water$fJ. Lucas.
210   $aLondon$cE. Stanford$d1874
215   $aVIII, 86 p., 5 tav.$cill.$d26 cm
610 0 $aAcque potabili$aApprovigionamento
610 0 $aPozzi d'acqua
676   $a628.114
700  1$aLucas,$bJ.$0332997
801  0$aIT$bUNINA$gRICA$2UNIMARC
901   $aBK
912   $a990000101450403321
952   $a13 AR 21 E 19$b4075$fFINBC
959   $aFINBC
996   $aHorizontal wells$9116233
997   $aUNINA
DB    $aING01

LEADER 03584nam  2200685 a 450 
001 9910963416303321
005 20251017110118.0
010   $a0-309-20959-5
010   $a1-283-01910-8
010   $a9786613019103
010   $a0-309-15890-7
035   $a(CKB)2550000000032026
035   $a(EBL)3378748
035   $a(SSID)ssj0000507437
035   $a(PQKBManifestationID)11344055
035   $a(PQKBTitleCode)TC0000507437
035   $a(PQKBWorkID)10562131
035   $a(PQKB)10436788
035   $a(MiAaPQ)EBC3378748
035   $a(Au-PeEL)EBL3378748
035   $a(CaPaEBR)ebr10454969
035   $a(CaONFJC)MIL301910
035   $a(OCoLC)923283190
035   $a(DNLM)1559514
035   $a(EXLCZ)992550000000032026
100   $a20110414d2011      uy         0
101 0 $aeng
135   $aurcn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aBuilding a national framework for the establishment of regulatory science for drug development $eworkshop summary /$fInstitute of Medicine of the National Academies ; Yeonwoo Lebovitz, Rebecca A. English, and Anne B. Claiborne, rapporteurs
205   $aFirst edition.
210   $aWashington, D.C. $cNational Academies Press$d2011
215   $a1 online resource (95 pages)
300   $a"Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy."
311 08$a0-309-15889-3 
320   $aIncludes bibliographical references.
327   $a""Front Matter""; ""Reviewers""; ""Contents""; ""Figures and Boxes""; ""Acronyms""; ""Preface""; ""1 Introduction""; ""2 Defining Regulatory Science""; ""3 The Urgent Need for Regulatory Science""; ""4 Barriers to Enhanced Regulatory Science""; ""5 Potential Models for Building a Regulatory Science Infrastructure""; ""6 Challenges in Engaging the Public Policy Community""; ""7 Envisioning Successful Regulatory Science at FDA""; ""8 Considering Next Steps""; ""References""; ""Appendix A: Agenda""; ""Appendix B: Participant Biographies""
330   $a"The Food and Drug Administration (FDA) is tasked with ensuring the safety and effectiveness of medicine. FDA's science base must be strong enough to make certain that regulatory decisions are based on the best scientific evidence. The IOM held a public workshop on February 26, 2010, to examine the state of regulatory science and to consider approaches for enhancing it."--Publisher's description.
606   $aPharmaceutical policy$zUnited States$vCongresses
606   $aDrug development$xGovernment policy$zUnited States$vCongresses
606   $aPharmaceutical industry$xGovernment policy$zUnited States$vCongresses
615  0$aPharmaceutical policy
615  0$aDrug development$xGovernment policy
615  0$aPharmaceutical industry$xGovernment policy
676   $a615.1
701   $aLebovitz$b Yeonwoo$01807991
701   $aEnglish$b Rebecca A$01805913
701   $aClaiborne$b Anne B$01805914
712 02$aInstitute of Medicine (U.S.).$bForum on Drug Discovery, Development, and Translation.
712 02$aInstitute of Medicine (U.S.).$bBoard on Health Sciences Policy.
712 12$aBuilding a National Framework for the Establishment of Regulatory Science for Drug Development$f(2010 :$eWashington, D.C.)
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910963416303321
996   $aBuilding a national framework for the establishment of regulatory science for drug development$94447240
997   $aUNINA